The global demand for Bioabsorbable Stents Market is presumed to reach the market size of nearly USD 834.07 Million by 2032 from USD 460.22 Million in 2023 with a CAGR of 6.83% under the study period 2024-2032.
Bioabsorbable stents are inserted into a human blood vessel to prevent or alleviate a blockage and are absorbed or dissolved by the body in due course. An ideal stent should have superior mechanical properties to provide the necessary vessel support during the required period. It must be biocompatible, have good deliverability to carry an antiproliferative drug to reduce restenosis, and have adequate degradation time. After a specific period, the stent disappears by re-establishing the normal morphology and physiology (motility, vessel geometry, and shear stress) of the blood vessel without creating an intense inflammatory response. The success of a stent largely depends on the selection of the material and the design. Absorbable stents are one of the most promising devices in the field of interventional cardiology.
MARKET DYNAMICS
High prevalence of cardiovascular disorders and increased preference for minimally invasive procedures among the global population will be the critical trending factors for the growth of the bioabsorbable stents market. High disposable income and inclination toward technologically advanced treatment methods will boost market growth. The increased efficiency of the treatment using these stents by reducing the chances of thrombosis and dual antiplatelet therapy among patients will be a market booster. The increasing geriatric population and the increased risk of coronary artery diseases due to unhealthy lifestyles will benefit market growth. The massive investments associated with this technology's development and the undesirable effects of stenting in the human body will be the major hurdles for this market's growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bioabsorbable Stents. The growth and trends of Bioabsorbable Stents industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Bioabsorbable Stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Biomaterial
Bioabsorbable Polymer-based Stents
Bioabsorbable Metallic Stents
By Application
Coronary Artery Disease
Peripheral Artery Disease
By Absorption Rate
Segmentation Slow Absorption Rate
Fast Absorption Rate
By End-user
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Bioabsorbable Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bioabsorbable Stents market include Amaranth Medical, Arterial Remodeling Technologies, Arterius Limited, B.Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Microport Scientific Corporation, Reva Medical, Terumo Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3.7.1 Market Attractiveness Analysis By Biomaterial
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Absorption Rate
3.7.4 Market Attractiveness Analysis By End-user
3.7.5 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY BIOMATERIAL
5.1. Overview By Biomaterial
5.2. Historical and Forecast Data
5.3. Analysis By Biomaterial
5.4. Bioabsorbable Polymer-based Stents Historic and Forecast Sales By Regions
5.5. Bioabsorbable Metallic Stents Historic and Forecast Sales By Regions
6. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Coronary Artery Disease Historic and Forecast Sales By Regions
6.5. Peripheral Artery Disease Historic and Forecast Sales By Regions
7. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY ABSORPTION RATE
7.1. Overview By Absorption Rate
7.2. Historical and Forecast Data
7.3. Analysis By Absorption Rate
7.4. Segmentation Slow Absorption Rate Historic and Forecast Sales By Regions
7.5. Fast Absorption Rate Historic and Forecast Sales By Regions
8. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY END-USER
8.1. Overview By End-user
8.2. Historical and Forecast Data
8.3. Analysis By End-user
8.4. Hospitals Historic and Forecast Sales By Regions
8.5. Cardiac Centers Historic and Forecast Sales By Regions
8.6. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
9. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
9.3.1 Overview, Historic and Forecast Data Sales Analysis
9.3.2 North America By Segment Sales Analysis
9.3.3 North America By Country Sales Analysis
9.3.4 United States Sales Analysis
9.3.5 Canada Sales Analysis
9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
9.4.1 Overview, Historic and Forecast Data Sales Analysis
9.4.2 Europe By Segment Sales Analysis
9.4.3 Europe By Country Sales Analysis
9.4.4 United Kingdom Sales Analysis
9.4.5 France Sales Analysis
9.4.6 Germany Sales Analysis
9.4.7 Italy Sales Analysis
9.4.8 Russia Sales Analysis
9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
9.5.1 Overview, Historic and Forecast Data Sales Analysis
9.5.2 Asia Pacific By Segment Sales Analysis
9.5.3 Asia Pacific By Country Sales Analysis
9.5.4 China Sales Analysis
9.5.5 India Sales Analysis
9.5.6 Japan Sales Analysis
9.5.7 South Korea Sales Analysis
9.5.8 Australia Sales Analysis
9.5.9 South East Asia Sales Analysis
9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
9.6.1 Overview, Historic and Forecast Data Sales Analysis
9.6.2 Latin America By Segment Sales Analysis
9.6.3 Latin America By Country Sales Analysis
9.6.4 Brazil Sales Analysis
9.6.5 Argentina Sales Analysis
9.6.6 Peru Sales Analysis
9.6.7 Chile Sales Analysis
9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
9.7.1 Overview, Historic and Forecast Data Sales Analysis
9.7.2 Middle East & Africa By Segment Sales Analysis
9.7.3 Middle East & Africa By Country Sales Analysis
9.7.4 Saudi Arabia Sales Analysis
9.7.5 UAE Sales Analysis
9.7.6 Israel Sales Analysis
9.7.7 South Africa Sales Analysis
9.7.8 Rest Of Middle East And Africa Sales Analysis
10. COMPETITIVE LANDSCAPE OF THE BIOABSORBABLE STENTS COMPANIES
10.1. Bioabsorbable Stents Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11. COMPANY PROFILES OF BIOABSORBABLE STENTS INDUSTRY
11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Amaranth Medical
11.3.1 Company Overview
11.3.2 Company Revenue
11.3.3 Products
11.3.4 Recent Developments
11.4. Arterial Remodeling Technologies
11.4.1 Company Overview
11.4.2 Company Revenue
11.4.3 Products
11.4.4 Recent Developments
11.5. Arterius Limited
11.5.1 Company Overview
11.5.2 Company Revenue
11.5.3 Products
11.5.4 Recent Developments
11.6. B.Braun Melsungen AG
11.6.1 Company Overview
11.6.2 Company Revenue
11.6.3 Products
11.6.4 Recent Developments
11.7. Biotronik SE & Co. KG
11.7.1 Company Overview
11.7.2 Company Revenue
11.7.3 Products
11.7.4 Recent Developments
11.8. Boston Scientific Corporation
11.8.1 Company Overview
11.8.2 Company Revenue
11.8.3 Products
11.8.4 Recent Developments
11.9. Elixir Medical Corporation
11.9.1 Company Overview
11.9.2 Company Revenue
11.9.3 Products
11.9.4 Recent Developments
11.10. Kyoto Medical Planning Co. Ltd.
11.10.1 Company Overview
11.10.2 Company Revenue
11.10.3 Products
11.10.4 Recent Developments
11.11. Microport Scientific Corporation
11.11.1 Company Overview
11.11.2 Company Revenue
11.11.3 Products
11.11.4 Recent Developments
11.12. Reva Medical
11.12.1 Company Overview
11.12.2 Company Revenue
11.12.3 Products
11.12.4 Recent Developments
11.13. Terumo Corporation
11.13.1 Company Overview
11.13.2 Company Revenue
11.13.3 Products
11.13.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies